| Model Number |
ONYXNG35022UX |
| Medical Device Problem Codes |
Material Deformation (2976); Positioning Problem (3009)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/07/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a procedure, one onyx frontier coronary drug eluting stent, the stent deformed in vivo during positioning.The stent strut was bent when attempted to advance the stent in the lesion.The lesion was pre-dilated with an nc balloon.After the stent could not be advanced, the device was removed and noticed the stent strut was bent.The procedure was completed with another size onyx stent.The target lesion was located in the mid left anterior descending (lad) artery.The lesion exhibited severe tortuosity and moderate calcification.The device was inspected prior to use with no issues noted.Negative prep was performed with no issues.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was encountered when advancing the device.Excessive force was not used during delivery.The procedure was completed with one 3.5x18mm onyx frontier stent.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the lesion was pre dilated with an non-medtronic nc balloon with no issues.There were no issues with the nc balloon.The procedure was completed with one 3.5x18mm onyx frontier stent being implanted successfully.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|